Proteomics Market

The global proteomics market is projected to reach USD 65.78 billion by 2030 from USD 36.32 billion in 2025, at a CAGR of 12.6% from 2025 to 2030. The growth of the global proteomics market is attributed to several key factors, including rising life-science R&D funding, expanding public–private research programs, and strong momentum in translational and clinical proteomics.

Several key players in the global proteomics market with a strong footprint include Thermo Fisher Scientific, Inc. (US), Danaher Corporation (US), Agilent Technologies, Inc. (US), Bio-Rad Laboratories (US), Revvity (US), Illumina Inc. (US), Promega Corporation (US), and Charles River Laboratories (US), among others. These companies operate across North America, Europe, and the Asia Pacific through direct sales, channel partners, and service networks. They also benefit from broad installed bases in pharma, biotech, academia, and clinical research labs. Their portfolios span advanced sample preparation and separation, high-resolution mass spectrometry and chromatography systems, multiplex and targeted protein platforms, and software for data processing and interpretation.

In September 2025, Illumina launched its Illumina Protein Prep assay, which can quantify about 9,500 human protein targets using NGS-based workflows to support large-scale multiomics.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US)

Thermo Fisher is a leading global player in proteomics, with a strong footprint in end-to-end workflows. Its Orbitrap mass spectrometers, LC systems, and automated sample prep solutions are widely used across pharma, CROs, and academic centers globally. The company also strengthens downstream workflows through data analysis and informatics that support large cohort and multiomics programs. With the addition of next-generation proteomics platforms in its broader life science portfolio, Thermo is positioning itself as a single-vendor partner for scalable discovery and translational proteomics across North America, Europe, and the Asia Pacific.

 Danaher Corporation (US)

Danaher supports the global proteomics market through SCIEX and Cytiva, spanning LC-MS/MS systems, separation workflows, and sample-prep and bioprocessing-aligned tools that feed protein analysis programs. Its platforms are used for both routine and advanced proteomics, including quantitative workflows that need consistency at scale. Danaher also benefits from a global customer base in pharma and biotech, where proteomics adoption is rising for biomarker validation and translational decision-making. Partnerships and workflow standardization efforts help increase accessibility of high-throughput proteomics in both established and emerging markets.

Agilent Technologies (US)

Agilent has global proteomics through integrated LC and LC-MS solutions, including triple-quadrupole and Q-TOF systems that support targeted and quantitative proteomics workflows. Its standardized consumables and software ecosystem help labs drive reproducible peptide and protein quantification across regions. Agilent’s strength in chromatography and sample front-end enables strong adoption in clinical research, bioanalytical labs, and multi-omics pipelines. Through continued application development in plasma proteomics and targeted panels, Agilent supports sensitive, scalable proteomics programs across global pharma, CRO, and academic networks.

Market Ranking

Thermo Fisher Scientific is the leader in combining Orbitrap mass spectrometers, high-plex proteomics platforms, and easy-to-use workflows. Its wide range of instruments, consumables, and software is helping the company capture both discovery, scale studies, and regulated translational programs from all major global markets. Danaher is expanding globally through platforms such as SCIEX (LC, MS/MS) and Cytiva (sample prep and workflow infrastructure) by offering standardized, high-throughput proteomics solutions. Agilent Technologies is a very significant player worldwide with its integrated LC-MS systems and a strong consumables and software ecosystem, which provides the means for sensitive, reproducible peptide and protein quantitation.

Related Reports:

Proteomics Market by Product (Spectroscopy, Chromatography, Electrophoresis, X-Ray Crystallography), Reagent, Service (Core Proteomics, Bioinformatics), Application (Diagnostic, Drug Discovery), End User (Hospital, Biopharma) - Global Forecast to 2030

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com